SGLT2 inhibitors and atherosclerosis-related outcomes: the good and the bad

2 September 2019 (16:40 - 16:57)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors and cardiovascular outcomes Diabetes and the Heart ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by